| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1026498313 |
| P356 | DOI | 10.1038/LABINVEST.3700590 |
| P8608 | Fatcat ID | release_bvhlkp7wdbdn7mzimnc4erffd4 |
| P698 | PubMed publication ID | 17558421 |
| P5875 | ResearchGate publication ID | 6279325 |
| P50 | author | Manlio Vinciguerra | Q37369918 |
| Valerio Pazienza | Q38544027 | ||
| P2093 | author name string | Paolo Pugnale | |
| Michelangelo Foti | |||
| Antoine Hadengue | |||
| Andrea De Gottardi | |||
| Antonino Sgroi | |||
| Florence Ravier-Dall'Antonia | |||
| Moulay Moukil | |||
| P2860 | cites work | ADRP/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells | Q28277520 |
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis | Q30811004 | ||
| Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. | Q31161488 | ||
| Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism | Q33830715 | ||
| Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth | Q34236816 | ||
| Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury | Q34359266 | ||
| A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease | Q81100393 | ||
| Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. | Q34415177 | ||
| Lipoapoptosis: its mechanism and its diseases | Q35047180 | ||
| Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. | Q35594723 | ||
| Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. | Q35598407 | ||
| Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease | Q35648642 | ||
| Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease | Q35792208 | ||
| Recent concepts in non-alcoholic fatty liver disease | Q36234172 | ||
| Insulin resistance: a metabolic pathway to chronic liver disease | Q36297331 | ||
| Nonalcoholic fatty liver disease in children | Q36352884 | ||
| Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. | Q36366205 | ||
| Tissue-specific roles of IRS proteins in insulin signaling and glucose transport | Q36386892 | ||
| Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. | Q38296226 | ||
| Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury | Q38354952 | ||
| Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes. | Q40372150 | ||
| Expression analysis of a human hepatic cell line in response to palmitate. | Q40461642 | ||
| Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model | Q40727614 | ||
| Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
| Hepatic steatosis and insulin resistance: does etiology make a difference? | Q42668260 | ||
| Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury | Q42984798 | ||
| Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. | Q42997321 | ||
| Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients | Q43041131 | ||
| The mechanisms underlying hepatitis C virus genotype 3-mediated liver damage | Q43047606 | ||
| Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis | Q43542965 | ||
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
| NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome | Q43875846 | ||
| Apolipoprotein synthesis in nonalcoholic steatohepatitis | Q43933950 | ||
| Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice | Q43966288 | ||
| Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes | Q44007180 | ||
| Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. | Q44493753 | ||
| Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway | Q44967749 | ||
| Impaired proliferation of non-parenchymal cells participates in an impairment of liver regeneration in db/db mice | Q46591524 | ||
| Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray | Q46848211 | ||
| Hepatic steatosis: innocent bystander or guilty party? | Q47993755 | ||
| Association of nonalcoholic fatty liver disease with insulin resistance. | Q51559831 | ||
| Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. | Q52537460 | ||
| Non-alcoholic fatty liver disease and insulin resistance: importance of risk factors and histological spectrum. | Q53851541 | ||
| Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis | Q58622840 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Nonalcoholic fatty liver disease | Q74119103 | ||
| In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease | Q79788222 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | steatosis | Q1365091 |
| P304 | page(s) | 792-806 | |
| P577 | publication date | 2007-06-11 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes | |
| P478 | volume | 87 |
| Q36080184 | A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics |
| Q37583600 | A functional, genome-wide evaluation of liposensitive yeast identifies the "ARE2 required for viability" (ARV1) gene product as a major component of eukaryotic fatty acid resistance |
| Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
| Q34181630 | Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. |
| Q34468914 | Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells |
| Q33552800 | C/EBP beta and C/EBP delta expression is elevated in the early phase of ethanol-induced hepatosteatosis in mice |
| Q37899938 | Cholesterol: recapitulation of its active role during liver regeneration |
| Q33635237 | Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening |
| Q38843888 | Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes |
| Q39578297 | Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells |
| Q39531917 | Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells. |
| Q24310600 | MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis |
| Q42023463 | Modeling Nonalcoholic Fatty Liver Disease with Human Pluripotent Stem Cell-Derived Immature Hepatocyte-Like Cells Reveals Activation of PLIN2 and Confirms Regulatory Functions of Peroxisome Proliferator-Activated Receptor Alpha |
| Q42079508 | Oleate inhibits steryl ester synthesis and causes liposensitivity in yeast. |
| Q47284771 | Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers |
| Q39208263 | Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. |
| Q40023832 | Quantifying hepatic steatosis - more than meets the eye. |
| Q41455293 | Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice. |
| Q36129673 | Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research |
| Q36407635 | Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients |
| Q46125862 | The Lou/C rat: a model of spontaneous food restriction associated with improved insulin sensitivity and decreased lipid storage in adipose tissue |
| Q35056293 | The effect of miRNA-122 in regulating fat deposition in a cell line model |
| Q35190820 | The use of fluorescent Nile red and BODIPY for lipid measurement in microalgae. |
| Q35633882 | Toxicogenomic biomarkers for liver toxicity |
| Q39689310 | Transcriptome profiling in response to adiponectin in human cancer-derived cells |
| Q39906678 | Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes |
Search more.